Product Information
LEVETIRACETAM 750 MG TABLET is a generic product labeled by Major Pharmaceuticals, priced at $0.1092 per EA under NDC 00904712561. Its NADAC has been published 246 times since Jan 19, 2022.
FDA first approved this application on Jan 15, 2009. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
750 mg/1
Manufacturer
Major PharmaceuticalsNDC
00904712561
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
LEVETIRACETAMApproval Type
Generic (ANDA)
FDA Application
ANDA078993FDA Approved
1/15/2009
TE Code
AB
On Market Since
1/15/2009
Pharmacological Classes
Price Statistics
The NADAC for LEVETIRACETAM 750 MG TABLET has been published 246 times since Jan 19, 2022, and over the history we have for it it has declined 27.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1092 per EA |
|---|---|
| All-time high | $0.1585 (Apr 13, 2022) |
| All-time low | $0.0954 (Nov 20, 2024) |
| 52-week high | $0.1170 |
| 52-week low | $0.1092 |
| Median price | $0.1269 |
| Average price | $0.1300 |
| Largest weekly change | -24.3% (Nov 20, 2024) |
| Weeks tracked | 246 |
| Tracking since | Jan 19, 2022 |
Generic Alternatives
The matcher finds 19 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 3% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Major Pharmaceuticals manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Levetiracetam market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LEVETIRACETAM 750 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LEVETIRACETAM 750 MG TABLET, manufactured by Major Pharmaceuticals, is $0.1092 per EA (NDC 00904712561), effective Sep 30, 2026.
How has the price of LEVETIRACETAM 750 MG TABLET changed over time?
Over the history we have for it, the NADAC for LEVETIRACETAM 750 MG TABLET has declined 27.4%. It has been tracked across 246 weekly CMS publications since Jan 19, 2022.
What are the highest and lowest recorded NADAC prices for LEVETIRACETAM 750 MG TABLET?
Since Jan 19, 2022, the NADAC for LEVETIRACETAM 750 MG TABLET has ranged from a low of $0.0954 (Nov 20, 2024) to a high of $0.1585 (Apr 13, 2022), with a median of $0.1269 per EA.
Are there cheaper alternatives to LEVETIRACETAM 750 MG TABLET?
Yes. 19 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LEVETIRACETAM 750 MG TABLET, is $0.1056 per EA — about 3% below LEVETIRACETAM 750 MG TABLET.
Who manufactures LEVETIRACETAM 750 MG TABLET?
LEVETIRACETAM 750 MG TABLET (NDC 00904712561) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.